Search for: "Boehringer Ingelheim Pharmaceutical, Inc"
Results 21 - 40
of 124
Sort by Relevance
|
Sort by Date
5 Aug 2016, 2:10 pm
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention (Posted by Tom Lamb at DrugInjuryWatch.com) This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors… [read post]
13 Jul 2016, 1:56 pm
About a month later, however, only those three diabetes drugs from Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
8 May 2016, 9:59 pm
KG; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
8 Jan 2016, 8:00 pm
Boehringer Ingelheim Pharmaceuticals v. [read post]
8 Jul 2015, 8:31 am
Labs., Inc., 625 F.2d 1055 (3d Cir. 1980) (holding unique coloring of prescription drug capsule constituted protectable trade dress); Boehringer Ingelheim G.m.b.H. v. [read post]
17 Mar 2015, 3:09 am
Boehringer Ingelheim Pharmaceuticals, Inc.). [read post]
9 Mar 2015, 2:38 pm
Litigation and Government Investigations at Boehringer Ingelheim Pharmaceuticals where she oversaw all U.S. litigation and government investigations. [read post]
16 Feb 2015, 3:44 am
Boehringer Ingelheim Pharmaceuticals, Inc., D. [read post]
5 Jun 2014, 7:06 am
Boehringer Ingelheim Pharmaceuticals, Inc., which was decided just a few months before I started my career in employment law. [read post]
3 Jun 2014, 4:41 pm
That same year, Boehringer Ingelheim Pharmaceuticals, Inc. made $1.5 billion in sales of Pradaxa. [read post]
3 Apr 2014, 5:00 am
Jan. 30, 2014) (“Actos”); In re Ethicon, Inc. [read post]
13 Feb 2014, 6:00 am
District Court Judge David Herndon from the Southern District of Illinois imposed close to $1 million in punitive damages on defendants Boehringer Ingelheim International GMBH (“BII”) and Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
28 Jan 2014, 11:53 am
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., and Boehringer Ingelheim Int’l. [read post]
25 Jan 2014, 9:43 am
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., No. 13-3898 (7th Cir. [read post]
15 Jan 2014, 5:43 am
Herndon of the Southern District of Illinois has ordered that Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
1 Aug 2013, 9:29 am
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
28 Jul 2013, 9:29 am
Some of the other diabetes drugs being investigated include Bydureon and Onglyza, sold by Bristol-Myers Squibb; AstraZeneca and Victoza from Novo Nordisk; Tradjenta from Eli Lilly and Boehringer Ingelheim; and Nesina from Takeda. [read post]
2 May 2013, 10:30 am
On March 26, 2013, Plaintiff Lisa Mulhall filed a claim in the Illinois Southern District Court against the manufacturers of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH, for causing her mother’s death. [read post]
31 Jan 2013, 12:57 pm
The plaintiffs brought a product liability claim against Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
26 Dec 2012, 1:35 pm
A Look At The Events And The Evidence Leading Up To This Latest FDA Action Concerning The Safety Of Pradaxa (Posted by Tom Lamb at DrugInjuryWatch.com) We set the stage with this December 19, 2012 drug company press release, "Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
